Analyst Ratings (USA)
Today’s analyst outlook was selectively positive but cautious on valuations. New coverage leaned bullish, with 40 of 57 initiations rated a Buy. Price-target cuts outnumbered increases 189 to 90, with notable reductions across utilities, real estate and financial stocks. Analysts still raised targets for selected technology, life sciences and energy names, pointing to stock-specific opportunities rather than broad optimism.
Updates (457)
10x Genomics (TXG) — Stifel Nicolaus set a US$70.00 price target.
10x Genomics (TXG) — TD Cowen maintained its Hold rating and raised its price target to US$70.00 from US$47.00.
AbbVie (ABBV) — RBC reiterated its Outperform rating with a US$280.00 price target.
ACADIA Pharmaceuticals (ACAD) — UBS downgraded its rating to Neutral from Buy and lowered its price target to US$23.00 from US$49.00.
Adaptive Biotechnologies (ADPT) — TD Cowen maintained its Buy rating and raised its price target to US$32.00 from US$28.00.
ADI Global Distribution Inc. Common Stock (ADIG) — JPMorgan maintained its Neutral rating and lowered its price target to US$20.00 from US$25.00.
Adobe (ADBE) — HSBC downgraded its rating to Hold from Buy and lowered its price target to US$267.00 from US$310.00.
ADT (ADT) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$7.25 from US$7.75.
Affirm (AFRM) — Goldman Sachs maintained its Buy rating and lowered its price target to US$103.00 from US$115.00.
Agilent Technologies (A) — Morgan Stanley maintained its Overweight rating and raised its price target to US$190.00 from US$175.00.
Agilent Technologies (A) — TD Cowen maintained its Buy rating and raised its price target to US$196.00 from US$180.00.
AIR Global (AIIR) — Cantor Fitzgerald initiated coverage with an Overweight rating and a US$11.03 price target.
Air Products (APD) — Barclays initiated coverage with an Overweight rating and a US$353.00 price target.
Albemarle (ALB) — Barclays initiated coverage with an Equal Weight rating and a US$109.00 price target.
Alliant Energy (LNT) — Barclays maintained its Equal Weight rating and lowered its price target to US$68.00 from US$73.00.
Allient (ALNT) — JPMorgan downgraded its rating to Neutral from Overweight with a US$120.00 price target.
Alpha Teknova (TKNO) — TD Cowen maintained its Buy rating and raised its price target to US$11.00 from US$7.00.
Alpine Income Property Trust (PINE) — Stifel Nicolaus set a US$21.25 price target.
Amer Sports (AS) — Jefferies initiated coverage with a Buy rating and a US$42.00 price target.
Ameren (AEE) — KeyCorp maintained its Overweight rating and raised its price target to US$122.00 from US$116.00.
American Electric (AEP) — KeyBanc upgraded its rating to Overweight from Sector Weight with a US$133.00 price target.
American Healthcare REIT (AHR) — Barclays maintained its Overweight rating and lowered its price target to US$60.00 from US$66.00.
American Healthcare REIT (AHR) — Raymond James initiated coverage with a Strong Buy rating and a US$62.00 price target.
American Healthcare REIT (AHR) — UBS maintained its Buy rating and lowered its price target to US$62.00 from US$63.00.
American Homes 4 Rent (AMH) — RBC maintained its Outperform rating and lowered its price target to US$35.00 from US$37.00.
American Outdoor Brands (AOUT) — Ladenburg Thalmann initiated coverage with a Buy rating and a US$22.00 price target.
AMERISAFE (AMSF) — Truist maintained its Hold rating and lowered its price target to US$27.00 from US$32.00.
Amgen (AMGN) — Guggenheim maintained its Neutral rating and lowered its price target to US$378.00 from US$388.00.
Amrize (AMRZ) — JPMorgan maintained its Neutral rating and lowered its price target to US$48.00 from US$52.00.
AngioDynamics (ANGO) — HC Wainwright maintained its Buy rating and lowered its price target to US$18.00 from US$19.00.
Anheuser-Busch InBev SA/NV (BUD) — TD Cowen maintained its Hold rating and lowered its price target to US$85.00 from US$89.00.
Apollo Global Management (APO) — UBS maintained its Buy rating and lowered its price target to US$163.00 from US$172.00.
Appian (APPN) — Barclays maintained its Underweight rating and raised its price target to US$30.00 from US$26.00.
Apple Hospitality REIT (APLE) — Barclays maintained its Equal Weight rating and raised its price target to US$18.00 from US$17.00.
Applied Aerospace & Defense (AADX) — RBC maintained its Outperform rating and lowered its price target to US$21.00 from US$24.00.
Applied Materials (AMAT) — Cantor Fitzgerald reiterated its Outperform rating.
AppLovin (APP) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$400.00 from US$450.00.
Arch Capital (ACGL) — Morgan Stanley downgraded its rating to Equal-Weight from Overweight and lowered its price target to US$100.00 from US$105.00.
Ares Management (ARES) — UBS maintained its Neutral rating and lowered its price target to US$134.00 from US$142.00.
Aritzia (ATZAF) — Jefferies downgraded its rating to Hold from Buy.
Ascentage Pharma (AAPG) — Citizens initiated coverage with a Mkt Outperform rating and a US$35.00 price target.
Ascentage Pharma Group International (AAPG) — Citigroup initiated coverage with an Outperform rating.
AST SpaceMobile (ASTS) — Piper Sandler downgraded its rating to Neutral from Overweight and lowered its price target to US$54.00 from US$98.00.
Astrazeneca (AZN) — Nordea Equity Research upgraded its rating to Buy from Sell.
AT&T (T) — Bernstein downgraded its rating to Mkt Perform from Outperform with a US$24.00 price target.
Atlas Copco (ATLKY) — Citigroup reiterated its Buy rating.
Atlassian (TEAM) — Barclays maintained its Overweight rating and raised its price target to US$222.00 from US$172.00.
Avantor (AVTR) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$15.00 from US$14.00.
Avantor (AVTR) — TD Cowen maintained its Hold rating and raised its price target to US$17.00 from US$15.00.
Avient (AVNT) — Barclays initiated coverage with an Equal Weight rating and a US$44.00 price target.
Axalta Coating Systems (AXTA) — Barclays initiated coverage with an Overweight rating and a US$45.00 price target.
Axon Enterprise (AXON) — TD Cowen reiterated its Buy rating.
Badger Meter (BMI) — Barclays maintained its Underweight rating and lowered its price target to US$111.00 from US$112.00.
Ball (BALL) — RBC maintained its Outperform rating and lowered its price target to US$73.00 from US$77.00.
BBVA Banco Frances (BBAR) — UBS maintained its Neutral rating and lowered its price target to US$15.00 from US$20.00.
BCE (BCE) — Barclays maintained its Equal Weight rating and lowered its price target to US$24.00 from US$25.00.
BCE Inc (BCE) — Canaccord Genuity upgraded its rating to Buy from Hold.
Bel Fuse (BELFB) — JPMorgan maintained its Overweight rating and lowered its price target to US$330.00 from US$380.00.
BellRing Brands (BRBR) — TD Cowen maintained its Hold rating and lowered its price target to US$9.00 from US$12.00.
Better Home & Finance (BETR) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$15.00 from US$25.00.
BHP Group (BHP) — Citigroup reiterated its Neutral rating.
Biodesix (BDSX) — TD Cowen maintained its Buy rating and raised its price target to US$40.00 from US$30.00.
BlackRock (BLK) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$1,468.00 from US$1,479.00.
Blackstone (BX) — UBS maintained its Neutral rating and lowered its price target to US$116.00 from US$122.00.
Bloom Energy (BE) — Roth Capital reiterated its Neutral rating with a US$260.00 price target.
Bob’s Discount Furniture (BOBS) — Evercore set a US$18.00 price target.
Boot Barn (BOOT) — Citigroup maintained its Buy rating and lowered its price target to US$180.00 from US$205.00.
Boston Scientific (BSX) — Mizuho set a US$55.00 price target.
Boyd Gaming (BYD) — Citigroup reiterated its Market Perform rating.
Boyd Gaming (BYD) — Goldman Sachs set a US$80.00 price target.
Bright Horizons Family Solutions (BFAM) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$64.00 from US$66.00.
BrightView (BV) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$11.50 from US$12.50.
Bristol Myers Squibb (BMY) — Bernstein reiterated its Market Perform rating.
Bristol Myers Squibb (BMY) — Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$60.00 from US$65.00.
Brookfield Asset Management (BAM) — UBS maintained its Neutral rating and lowered its price target to US$49.00 from US$55.00.
Brookfield Infrastructure (BIPC) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$48.00 from US$50.00.
Brookfield Infrastructure Partners (BIP) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$48.00 from US$50.00.
Brookfield Renewable (BEPC) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$37.00 from US$42.00.
Brookfield Renewable Partners (BEP) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$37.00 from US$42.00.
Bruker (BRKR) — TD Cowen maintained its Hold rating and raised its price target to US$62.00 from US$60.00.
BWX Technologies (BWXT) — JPMorgan maintained its Overweight rating and lowered its price target to US$190.00 from US$230.00.
Cadre (CDRE) — JPMorgan maintained its Overweight rating and lowered its price target to US$35.00 from US$45.00.
CAE (CAE) — Jefferies maintained its Hold rating and lowered its price target to US$26.00 from US$28.00.
Camden Property Trust (CPT) — RBC maintained its Sector Perform rating and lowered its price target to US$101.00 from US$111.00.
Camping World (CWH) — Citigroup maintained its Buy rating and lowered its price target to US$7.00 from US$8.00.
Cardinal Energy (CRLFF) — RBC downgraded its rating to Sector Perform from Outperform.
CareTrust REIT (CTRE) — Citigroup reiterated its Market Outperform rating.
CareTrust REIT (CTRE) — UBS maintained its Buy rating and lowered its price target to US$44.00 from US$48.00.
CareTrust REIT (CTRE) — Wedbush set a US$44.00 price target.
Caris Life Sciences (CAI) — TD Cowen maintained its Buy rating and raised its price target to US$36.00 from US$30.00.
Carlisle Companies (CSL) — Baird maintained its Outperform rating and lowered its price target to US$402.00 from US$412.00.
Carlyle Group (CG) — UBS maintained its Buy rating and lowered its price target to US$60.00 from US$70.00.
Carnival (CCL) — Tigress Financial reiterated its Buy rating with a US$42.00 price target.
CECO Environmental (CECO) — JPMorgan maintained its Overweight rating and lowered its price target to US$110.00 from US$130.00.
Celanese (CE) — Barclays initiated coverage with an Equal Weight rating and a US$49.00 price target.
Celanese (CE) — RBC maintained its Sector Perform rating and raised its price target to US$46.00 from US$45.00.
Celsius (CELH) — TD Cowen maintained its Buy rating and lowered its price target to US$35.00 from US$41.00.
CenterPoint Energy (CNP) — JPMorgan maintained its Neutral rating and lowered its price target to US$44.00 from US$46.00.
CenterPoint Energy (CNP) — KeyCorp maintained its Overweight rating and lowered its price target to US$44.00 from US$46.00.
Certara (CERT) — TD Cowen maintained its Buy rating and raised its price target to US$11.00 from US$9.00.
Charles Schwab (SCHW) — Truist maintained its Buy rating and lowered its price target to US$125.00 from US$130.00.
Chemours (CC) — Barclays initiated coverage with an Equal Weight rating and a US$16.00 price target.
Chemours (CC) — RBC downgraded its rating to Sector Perform from Outperform with a US$14.00 price target.
Churchill Downs (CHDN) — Citigroup reiterated its Market Outperform rating.
Churchill Downs (CHDN) — Citizens maintained its Market Outperform rating and lowered its price target to US$131.00 from US$137.00.
Churchill Downs (CHDN) — RBC set a US$131.00 price target.
Citigroup (C) — Loop Capital set a US$155.00 price target.
Citizens (CIZN) — Citigroup changed its rating to Market Outperform from Market Perform.
Clorox (CLX) — TD Cowen maintained its Hold rating and lowered its price target to US$80.00 from US$85.00.
Cloudflare (NET) — TD Cowen maintained its Buy rating and raised its price target to US$375.00 from US$355.00.
CoastalSouth Bancshares (COSO) — Brean Capital initiated coverage with a Buy rating and a US$33.00 price target.
Cognizant Technology Solutions (CTSH) — TD Cowen maintained its Hold rating and raised its price target to US$60.00 from US$54.00.
Coinbase Global (COIN) — Citigroup maintained its Buy rating and raised its price target to US$230.00 from US$210.00.
Columbia Banking (COLB) — Deutsche Bank initiated coverage with a Hold rating and a US$32.00 price target.
Comcast (CMCSA) — Bernstein reiterated its Market Perform rating with a US$23.00 price target.
Compass Diversified (CODI) — Compass Point set a US$17.00 price target.
Compass Diversified (CODI) — Ladenburg Thalmann initiated coverage with a Buy rating and a US$17.00 price target.
Consolidated Edison (ED) — KeyCorp maintained its Underweight rating and lowered its price target to US$87.00 from US$94.00.
Contineum Therapeutics (CTNM) — Baird downgraded its rating to Neutral from Outperform with a US$14.00 price target.
CRH (CRH) — JPMorgan maintained its Overweight rating and lowered its price target to US$115.00 from US$140.00.
CryoPort (CYRX) — Baird set a US$26.00 price target.
CryoPort (CYRX) — BTIG Research maintained its Buy rating and raised its price target to US$26.00 from US$25.00.
CryoPort (CYRX) — Piper Sandler upgraded its rating to Buy.
CytomX Therapeutics (CTMX) — Cantor Fitzgerald reiterated its Overweight rating.
Danaher (DHR) — TD Cowen maintained its Buy rating and raised its price target to US$255.00 from US$236.00.
Datadog (DDOG) — Barclays maintained its Overweight rating and raised its price target to US$300.00 from US$290.00.
DexCom (DXCM) — Mizuho set a US$100.00 price target.
Diamondback Energy (FANG) — Stephens reiterated its Outperform rating.
DigitalOcean (DOCN) — KeyCorp reiterated its Overweight rating.
Domino’s Pizza (DPZ) — TD Cowen reiterated its Hold rating with a US$320.00 price target.
Dow (DOW) — Barclays initiated coverage with an Underweight rating and a US$30.00 price target.
Duke Energy (DUK) — JPMorgan maintained its Neutral rating and lowered its price target to US$130.00 from US$137.00.
Duke Energy (DUK) — KeyCorp maintained its Overweight rating and lowered its price target to US$128.00 from US$139.00.
DuPont (DD) — Barclays initiated coverage with an Overweight rating and a US$156.00 price target.
Dynatrace (DT) — Barclays maintained its Overweight rating and raised its price target to US$71.00 from US$60.00.
Eagle Materials (EXP) — JPMorgan maintained its Neutral rating and lowered its price target to US$200.00 from US$225.00.
EagleRock Land (EROK) — JPMorgan maintained its Overweight rating and lowered its price target to US$27.00 from US$29.00.
Eastman Chemical (EMN) — Barclays initiated coverage with an Equal Weight rating and a US$72.00 price target.
Eastman Chemical (EMN) — RBC maintained its Sector Perform rating and lowered its price target to US$65.00 from US$74.00.
Electra Therapeutics (ETRA) — Cantor Fitzgerald initiated coverage with an Overweight rating.
Electra Therapeutics (ETRA) — Evercore initiated coverage with an Outperform rating and a US$36.00 price target.
Electra Therapeutics (ETRA) — Jefferies initiated coverage with a Buy rating and a US$32.00 price target.
Electra Therapeutics (ETRA) — TD Cowen initiated coverage with a Buy rating.
Element Solutions (ESI) — Barclays initiated coverage with an Overweight rating and a US$53.00 price target.
Encore Capital Group (ECPG) — Northland Securities set a US$124.00 price target.
Enerflex (EFXT) — CIBC upgraded its rating to Sector Outperform from Neutral with a US$35.00 price target.
Energy Transfer (ET) — Mizuho set a US$26.00 price target.
Enlight Renewable Energy (ENLT) — Mizuho maintained its Underperform rating and lowered its price target to US$41.00 from US$45.00.
Enovix (ENVX) — Northland Securities set a US$5.00 price target.
Entegris (ENTG) — Barclays initiated coverage with an Overweight rating and a US$212.00 price target.
Entergy (ETR) — JPMorgan maintained its Overweight rating and lowered its price target to US$130.00 from US$137.00.
Entergy (ETR) — KeyCorp maintained its Overweight rating and lowered its price target to US$118.00 from US$123.00.
Envoy Medical (COCH) — HC Wainwright reiterated its Buy rating.
Equifax (EFX) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$205.00 from US$225.00.
Equifax (EFX) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$190.00 from US$245.00.
Equity Lifestyle Properties (ELS) — RBC maintained its Outperform rating and lowered its price target to US$68.00 from US$71.00.
Ero Copper (ERO) — Scotiabank downgraded its rating to Sector Perform from Sector Outperform.
Escalade (ESCA) — Ladenburg Thalmann initiated coverage with a Neutral rating.
ESCO Technologies (ESE) — JPMorgan maintained its Overweight rating and lowered its price target to US$350.00 from US$420.00.
Essex Property Trust (ESS) — RBC maintained its Outperform rating and lowered its price target to US$298.00 from US$312.00.
eToro Group (ETOR) — Susquehanna maintained its Positive rating and lowered its price target to US$46.00 from US$51.00.
Evergy (EVRG) — BMO Capital Markets maintained its Outperform rating and lowered its price target to US$85.00 from US$89.00.
Evergy (EVRG) — DA Davidson set a US$85.00 price target.
Exagen (XGN) — TD Cowen maintained its Buy rating and raised its price target to US$11.00 from US$10.00.
Exelon (EXC) — KeyBanc upgraded its rating to Sector Weight from Underweight.
FactSet Research Systems (FDS) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$314.00 from US$300.00.
Fair Isaac (FICO) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$1,100.00 from US$1,650.00.
Fair Isaac (FICO) — Raymond James maintained its Outperform rating and lowered its price target to US$1,230.00 from US$1,750.00.
Fastenal (FAST) — DA Davidson set a US$51.00 price target.
Fidelity National Information Services (FIS) — Goldman Sachs maintained its Buy rating and lowered its price target to US$44.00 from US$52.00.
Fidelity National Information Services (FIS) — Susquehanna maintained its Neutral rating and lowered its price target to US$37.00 from US$46.00.
First Tracks Biotherapeutics (TRAX) — Canaccord Genuity maintained its Buy rating and raised its price target to US$60.00 from US$50.00.
First Tracks Biotherapeutics (TRAX) — Evercore reiterated its Outperform rating with a US$70.00 price target.
FirstEnergy (FE) — New Street Research set a US$47.00 price target.
Five9 (FIVN) — Barclays maintained its Overweight rating and raised its price target to US$40.00 from US$34.00.
Floor & Decor (FND) — Citigroup maintained its Neutral rating and lowered its price target to US$49.00 from US$59.00.
Floor & Decor (FND) — Evercore set a US$50.00 price target.
Flutter Entertainment (FLUT) — Citizens maintained its Market Outperform rating and lowered its price target to US$129.00 from US$145.00.
FMC (FMC) — Mizuho maintained its Outperform rating and lowered its price target to US$12.00 from US$15.00.
Foghorn Therapeutics (FHTX) — Evercore downgraded its rating to In-line from Outperform with a US$3.00 price target.
FormFactor (FORM) — Stifel Nicolaus set a US$115.00 price target.
Fortinet (FTNT) — TD Cowen maintained its Buy rating and raised its price target to US$225.00 from US$215.00.
Freshpet (FRPT) — TD Cowen maintained its Buy rating and lowered its price target to US$80.00 from US$85.00.
Freshworks (FRSH) — Cantor Fitzgerald reiterated its Overweight rating.
Galaxy Digital (GLXY) — Citigroup upgraded its rating to Buy from Neutral and raised its price target to US$28.00 from US$26.00.
Galp Energia SGPS (GLPEY) — Citigroup reiterated its Neutral rating.
Gartner (IT) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$212.00 from US$206.00.
GE Vernova (GEV) — Guggenheim reiterated its Buy rating with a US$1,450.00 price target.
Gemini Space Station (GEMI) — Citigroup upgraded its rating to Neutral from Sell and raised its price target to US$4.75 from US$3.20.
Genesis Energy (GEL) — RBC maintained its Outperform rating and lowered its price target to US$17.00 from US$18.00.
Ginkgo Bioworks (DNA) — TD Cowen maintained its Hold rating and raised its price target to US$11.00 from US$9.00.
Glaukos (GKOS) — Mizuho set a US$190.00 price target.
Globant (GLOB) — Wells Fargo resumed coverage with an Equal Weight rating and a US$39.00 price target.
Globant (GLOB) — Wells Fargo & Company initiated coverage with an Equal Weight rating and lowered its price target to US$39.00 from US$42.00.
Goosehead Insurance (GSHD) — Truist maintained its Hold rating and lowered its price target to US$48.00 from US$58.00.
Gossamer Bio (GOSS) — Chardan initiated coverage with a Buy rating and a US$160.00 price target.
GRAIL (GRAL) — TD Cowen maintained its Buy rating and raised its price target to US$180.00 from US$88.00.
Graphic Packaging (GPK) — RBC maintained its Sector Perform rating and lowered its price target to US$9.00 from US$10.00.
Grupo Financiero Galicia (GGAL) — UBS maintained its Neutral rating and lowered its price target to US$45.00 from US$60.00.
Halozyme Therapeutics (HALO) — TD Cowen maintained its Buy rating and raised its price target to US$130.00 from US$105.00.
Hamilton Lane (HLNE) — UBS maintained its Buy rating and lowered its price target to US$115.00 from US$131.00.
Harmony Biosciences (HRMY) — HC Wainwright reiterated its Buy rating with a US$55.00 price target.
Hasbro (HAS) — Citigroup maintained its Buy rating and raised its price target to US$117.00 from US$107.00.
Hawkins (HWKN) — Barclays maintained its Equal Weight rating and lowered its price target to US$141.00 from US$142.00.
Healthcare Realty Trust (HR) — UBS maintained its Neutral rating and lowered its price target to US$18.00 from US$21.00.
Healthpeak Properties (DOC) — Barclays maintained its Equal Weight rating and lowered its price target to US$21.00 from US$24.00.
Healthpeak Properties (DOC) — UBS maintained its Neutral rating and lowered its price target to US$20.00 from US$21.50.
Hershey (HSY) — TD Cowen maintained its Buy rating and lowered its price target to US$198.00 from US$210.00.
Hess Midstream Partners (HESM) — Citigroup maintained its Neutral rating and lowered its price target to US$33.00 from US$37.00.
Hess Midstream Partners (HESM) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$30.00 from US$39.00.
Hess Midstream Partners (HESM) — UBS maintained its Neutral rating and lowered its price target to US$34.00 from US$37.00.
Host Hotels & Resorts (HST) — Barclays maintained its Equal Weight rating and raised its price target to US$25.00 from US$24.00.
Humana (HUM) — Mizuho maintained its Outperform rating and raised its price target to US$495.00 from US$468.00.
Huntsman (HUN) — Barclays initiated coverage with an Equal Weight rating and a US$10.00 price target.
Huntsman (HUN) — RBC maintained its Sector Perform rating and lowered its price target to US$9.00 from US$10.00.
Hyatt Hotels (H) — Susquehanna maintained its Neutral rating and lowered its price target to US$180.00 from US$185.00.
Illumina (ILMN) — TD Cowen maintained its Hold rating and raised its price target to US$270.00 from US$210.00.
Immatics (IMTX) — Stifel Nicolaus set a US$15.00 price target.
Incyte (INCY) — Benchmark reiterated its Buy rating.
Incyte (INCY) — HC Wainwright reiterated its Buy rating with a US$152.00 price target.
Inhibikase Therapeutics (IKT) — Chardan initiated coverage with a Neutral rating and a US$1.50 price target.
Inspire Medical Systems (INSP) — Mizuho set a US$75.00 price target.
Inspired Entertainment (INSE) — Citigroup reiterated its Market Outperform rating.
Inspired Entertainment (INSE) — Citizens maintained its Market Outperform rating and lowered its price target to US$9.00 from US$11.00.
International Business Machines (IBM) — RBC reiterated its Outperform rating with a US$270.00 price target.
International Business Machines (IBM) — UBS reiterated its Neutral rating.
Intuitive Surgical (ISRG) — Mizuho set a US$415.00 price target.
Intuitive Surgical (ISRG) — UBS reiterated its Buy rating.
Invesco (IVZ) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$36.00 from US$34.00.
Invesco (IVZ) — UBS set a US$36.00 price target.
Invitation Home (INVH) — RBC maintained its Sector Perform rating and lowered its price target to US$29.00 from US$31.00.
IonQ (IONQ) — Rosenblatt Securities reiterated its Buy rating with a US$100.00 price target.
IonQ (IONQ) — Wedbush reiterated its Outperform rating with a US$75.00 price target.
Iovance Biotherapeutics (IOVA) — Barclays maintained its Overweight rating and raised its price target to US$18.00 from US$15.00.
IRSA Inversiones (IRS) — BofA Securities initiated coverage with a Buy rating and a US$23.60 price target.
James Hardie Industries (JHX) — Baird maintained its Outperform rating and lowered its price target to US$32.00 from US$34.00.
JAN (JAN) — Barclays maintained its Overweight rating and lowered its price target to US$33.00 from US$34.00.
JD.com (JD) — BofA Securities maintained its Buy rating and lowered its price target to US$37.00 from US$38.00.
JPMorgan Chase & Co. (JPM) — Goldman Sachs reiterated its Outperform rating with a US$392.00 price target.
Kimberly-Clark (KMB) — TD Cowen maintained its Hold rating and lowered its price target to US$97.00 from US$104.00.
Kinetik (KNTK) — Barclays maintained its Equal Weight rating and raised its price target to US$56.00 from US$51.00.
KKR & Co. Inc. (KKR) — UBS maintained its Buy rating and lowered its price target to US$122.00 from US$123.00.
Knife River (KNF) — JPMorgan maintained its Underweight rating and lowered its price target to US$63.00 from US$73.00.
Knight-Swift Transportation (KNX) — UBS maintained its Buy rating and lowered its price target to US$82.00 from US$94.00.
Kroger (KR) — UBS reiterated its Neutral rating.
Kyntra Bio (KYNB) — Maxim initiated coverage with a Buy rating and a US$35.00 price target.
Lantheus Holdings (LNTH) — Mizuho downgraded its rating to Neutral from Outperform and lowered its price target to US$109.00 from US$115.00.
Las Vegas Sands (LVS) — Goldman Sachs reiterated its Buy rating with a US$47.00 price target.
Lazard (LAZ) — Goldman Sachs maintained its Sell rating and lowered its price target to US$32.00 from US$36.00.
Legend Biotech (LEGN) — Barclays maintained its Overweight rating and lowered its price target to US$68.00 from US$74.00.
Liftoff Mobile (LFTO) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$20.00 from US$30.00.
Linde plc (LIN) — Barclays initiated coverage with an Overweight rating and a US$577.00 price target.
Live Nation Entertainment (LYV) — Bernstein reiterated its Outperform rating with a US$220.00 price target.
Logitech International (LOGI) — JPMorgan maintained its Neutral rating and lowered its price target to US$94.00 from US$102.00.
LPL Financial (LPLA) — Truist set a US$354.00 price target.
LyondellBasell (LYB) — Barclays initiated coverage with an Equal Weight rating and a US$66.00 price target.
LyondellBasell Industries (LYB) — RBC maintained its Outperform rating and lowered its price target to US$68.00 from US$72.00.
Macro Bank (BMA) — UBS maintained its Buy rating and lowered its price target to US$90.00 from US$130.00.
ManpowerGroup (MAN) — UBS maintained its Neutral rating and raised its price target to US$56.00 from US$55.00.
Marathon Petroleum (MPC) — Citigroup maintained its Neutral rating and raised its price target to US$518.00 from US$318.00.
Martin Marietta Materials (MLM) — JPMorgan maintained its Overweight rating and lowered its price target to US$650.00 from US$680.00.
Matson (MATX) — JPMorgan maintained its Overweight rating and raised its price target to US$310.00 from US$270.00.
Mattel (MAT) — Citigroup maintained its Neutral rating and raised its price target to US$17.00 from US$15.00.
MDA Space (MDA) — Jefferies reiterated its Buy rating.
MercadoLibre (MELI) — Citigroup maintained its Neutral rating and lowered its price target to US$2,100.00 from US$2,150.00.
Meta Platforms (META) — KeyCorp reiterated its Overweight rating with a US$900.00 price target.
Meta Platforms (META) — Pivotal Research maintained its Buy rating and raised its price target to US$930.00 from US$790.00.
Meta Platforms (META) — Rosenblatt Securities reiterated its Buy rating with a US$886.00 price target.
Meta Platforms (META) — Truist maintained its Buy rating and raised its price target to US$1,000.00 from US$763.00.
Mettler-Toledo International (MTD) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$1,575.00 from US$1,450.00.
MGM Resorts International (MGM) — Goldman Sachs set a US$30.00 price target.
Micron Technology (MU) — Rosenblatt Securities reiterated its Buy rating with a US$1,900.00 price target.
Microsoft (MSFT) — Barclays maintained its Overweight rating and raised its price target to US$600.00 from US$512.00.
Mid-America Apartment Communities (MAA) — RBC maintained its Sector Perform rating and lowered its price target to US$127.00 from US$138.00.
MiniMed (MMED) — Rothschild & Co Redburn initiated coverage with a Buy rating and a US$30.00 price target.
Mirum Pharmaceuticals (MIRM) — Evercore reiterated its Outperform rating with a US$146.00 price target.
Molson Coors Beverage (TAP) — TD Cowen maintained its Hold rating and lowered its price target to US$37.00 from US$43.00.
MongoDB (MDB) — Needham & Company LLC reiterated its Buy rating with a US$430.00 price target.
Moody’s (MCO) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$490.00 from US$515.00.
Moog (MOG.A) — JPMorgan maintained its Overweight rating and lowered its price target to US$480.00 from US$520.00.
Morningstar (MORN) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$237.00 from US$230.00.
Mosaic (MOS) — Mizuho maintained its Neutral rating and lowered its price target to US$22.00 from US$25.00.
Mplx (MPLX) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$64.00 from US$66.00.
MSC Industrial (MSM) — Barclays initiated coverage with an Overweight rating and a US$152.00 price target.
MSC Industrial Direct (MSM) — DA Davidson set a US$155.00 price target.
MSCI (MSCI) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$662.00 from US$700.00.
Myriad Genetics (MYGN) — TD Cowen maintained its Hold rating and raised its price target to US$4.50 from US$4.00.
Natera (NTRA) — TD Cowen maintained its Buy rating and raised its price target to US$480.00 from US$340.00.
National Healthcare Properties (NHP) — Raymond James initiated coverage with an Outperform rating and a US$20.00 price target.
NatWest Group plc (NWG) — Barclays upgraded its rating to Overweight from Equal Weight.
NCR Voyix (VYX) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$8.00 from US$9.75.
Netflix (NFLX) — Huber Research downgraded its rating to Underweight from Buy.
Netflix (NFLX) — KeyCorp maintained its Overweight rating and lowered its price target to US$85.00 from US$92.00.
Nextpower (NXT) — Barclays maintained its Overweight rating and lowered its price target to US$146.00 from US$147.00.
NIQ Global Intelligence (NIQ) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$22.00 from US$20.00.
NiSource (NI) — KeyCorp maintained its Overweight rating and lowered its price target to US$48.00 from US$50.00.
Nurix Therapeutics (NRIX) — Baird maintained its Outperform rating and raised its price target to US$36.00 from US$33.00.
Nurix Therapeutics (NRIX) — Needham & Company LLC reiterated its Buy rating with a US$34.00 price target.
Nurix Therapeutics (NRIX) — Oppenheimer maintained its Outperform rating and raised its price target to US$32.00 from US$28.00.
Nurix Therapeutics (NRIX) — RBC maintained its Outperform rating and lowered its price target to US$35.00 from US$36.00.
Nurix Therapeutics (NRIX) — Stifel Nicolaus set a US$41.00 price target.
Nurix Therapeutics (NRIX) — Truist maintained its Buy rating and lowered its price target to US$33.00 from US$34.00.
O-I Glass (OI) — RBC maintained its Sector Perform rating and lowered its price target to US$7.00 from US$8.00.
Olin (OLN) — Barclays initiated coverage with an Equal Weight rating and a US$18.00 price target.
Olin (OLN) — RBC maintained its Sector Perform rating and lowered its price target to US$16.00 from US$20.00.
Ollie’s Bargain Outlet (OLLI) — Gordon Haskett upgraded its rating to Buy from Accumulate with a US$105.00 price target.
Omega Healthcare Investors (OHI) — Barclays maintained its Underweight rating and lowered its price target to US$48.00 from US$50.00.
Omega Healthcare Investors (OHI) — UBS maintained its Buy rating and lowered its price target to US$52.00 from US$54.00.
Once Upon A Farm (OFRM) — TD Cowen maintained its Hold rating and lowered its price target to US$18.00 from US$20.00.
ONEOK (OKE) — Jefferies reiterated its Hold rating with a US$94.00 price target.
Orion Group (ORN) — JPMorgan maintained its Overweight rating and lowered its price target to US$14.00 from US$16.00.
Orion180 Insurance Group (OIG) — Citigroup initiated coverage with a Market Outperform rating.
Orion180 Insurance Group (OIG) — Citizens initiated coverage with a Mkt Outperform rating and a US$20.00 price target.
Orion180 Insurance Group (OIG) — Deutsche Bank initiated coverage with a Buy rating and a US$12.90 price target.
Orion180 Insurance Group (OIG) — Goldman Sachs initiated coverage with a Buy rating and a US$13.00 price target.
Orion180 Insurance Group (OIG) — Raymond James initiated coverage with a Mkt Perform rating.
Orion180 Insurance Group (OIG) — RBC initiated coverage with an Outperform rating and a US$15.00 price target.
Orion180 Insurance Group (OIG) — UBS initiated coverage with a Buy rating and a US$14.00 price target.
Ovintiv (OVV) — RBC maintained its Outperform rating and raised its price target to US$90.00 from US$85.00.
Pacific Gas & Electric (PCG) — UBS reiterated its Neutral rating.
Palisade Bio (PALI) — HC Wainwright reiterated its Buy rating with a US$7.00 price target.
Patrick Industries (PATK) — BMO Capital Markets maintained its Outperform rating and lowered its price target to US$100.00 from US$120.00.
Paycom Software (PAYC) — Barclays maintained its Equal Weight rating and raised its price target to US$250.00 from US$210.00.
Paylocity (PCTY) — Barclays maintained its Equal Weight rating and raised its price target to US$162.00 from US$154.00.
Pegasystems (PEGA) — Barclays maintained its Overweight rating and raised its price target to US$43.00 from US$39.00.
Pegasystems (PEGA) — Citigroup maintained its Buy rating and lowered its price target to US$52.00 from US$55.00.
PENN Entertainment (PENN) — Citigroup reiterated its Market Outperform rating.
PENN Entertainment (PENN) — Goldman Sachs set a US$23.00 price target.
PENN Entertainment (PENN) — Piper Sandler upgraded its rating to Buy from Neutral with a US$26.00 price target.
Perimeter Solutions (PRM) — JPMorgan maintained its Overweight rating and lowered its price target to US$40.00 from US$45.00.
Pershing Square, Inc. (PS) — BofA Securities downgraded its rating to Underperform from Neutral and lowered its price target to US$38.00 from US$54.00.
Pfizer (PFE) — Guggenheim reiterated its Buy rating.
Phillips 66 (PSX) — Citigroup maintained its Neutral rating and raised its price target to US$297.00 from US$217.00.
Phoenix Education Partners (PXED) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$38.00 from US$40.00.
Planet Fitness (PLNT) — KeyCorp reiterated its Overweight rating.
Powell Industries (POWL) — JPMorgan maintained its Overweight rating and lowered its price target to US$250.00 from US$300.00.
PPG Industries (PPG) — Barclays initiated coverage with an Overweight rating and a US$136.00 price target.
Prologis (PLD) — Scotiabank upgraded its rating to Sector Outperform from Sector Perform with a US$150.00 price target.
Pulse Biosciences (PLSE) — Mizuho set a US$55.00 price target.
Pulse Biosciences (PLSE) — Oppenheimer maintained its Outperform rating and raised its price target to US$60.00 from US$35.00.
Qnity Electronics (Q) — Barclays initiated coverage with an Overweight rating and a US$211.00 price target.
Qualys (QLYS) — Morgan Stanley set a US$200.00 price target.
Qualys (QLYS) — TD Cowen maintained its Hold rating and raised its price target to US$200.00 from US$170.00.
Quanterix (QTRX) — TD Cowen maintained its Hold rating and raised its price target to US$3.50 from US$3.00.
QXO (QXO) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$16.00 from US$18.00.
Raymond James Financial (RJF) — Truist maintained its Hold rating and lowered its price target to US$166.00 from US$188.00.
Red Rock Resorts (RRR) — Goldman Sachs reiterated its Buy rating with a US$65.00 price target.
Republic Services (RSG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$219.00 from US$232.00.
ResMed (RMD) — Mizuho set a US$240.00 price target.
Revvity (RVTY) — TD Cowen maintained its Buy rating and raised its price target to US$175.00 from US$130.00.
Rexford Industrial Realty (REXR) — Mizuho upgraded its rating to Outperform from Neutral and raised its price target to US$41.00 from US$38.00.
Richardson Electronics (RELL) — Northland Securities set a US$26.00 price target.
Rio Tinto (RIO) — Citigroup reiterated its Neutral rating.
Riskified (RSKD) — Goldman Sachs maintained its Sell rating and raised its price target to US$7.50 from US$5.50.
RLJ Lodging Trust (RLJ) — Barclays maintained its Underweight rating and raised its price target to US$12.00 from US$11.00.
Robinhood Markets (HOOD) — Truist maintained its Buy rating and raised its price target to US$134.00 from US$130.00.
Rogers Communication (RCI) — Barclays maintained its Equal Weight rating and lowered its price target to US$35.00 from US$36.00.
Rollins (ROL) — JPMorgan maintained its Neutral rating and lowered its price target to US$35.00 from US$40.00.
Rollins (ROL) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$43.00 from US$45.00.
RPM Inc (RPM) — Barclays initiated coverage with an Equal Weight rating and a US$107.00 price target.
RTX (RTX) — Deutsche Bank downgraded its rating to Hold from Buy with a US$208.00 price target.
Ryman Hospitality Properties (RHP) — Barclays maintained its Overweight rating and lowered its price target to US$143.00 from US$147.00.
S&P Global (SPGI) — BMO Capital Markets maintained its Outperform rating and lowered its price target to US$500.00 from US$505.00.
Sabra Healthcare REIT (SBRA) — Barclays maintained its Equal Weight rating and lowered its price target to US$21.00 from US$23.00.
Sabra Healthcare REIT (SBRA) — UBS maintained its Neutral rating and lowered its price target to US$20.00 from US$21.00.
SAP (SAP) — Barclays maintained its Overweight rating and raised its price target to US$243.00 from US$242.00.
Schrodinger (SDGR) — TD Cowen maintained its Buy rating and raised its price target to US$31.00 from US$20.00.
Scorpio Tankers (STNG) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$90.00 from US$76.00.
Seacoast Banking Corporation of Florida (SBCF) — Raymond James maintained its Outperform rating and lowered its price target to US$36.00 from US$37.00.
Securitize, Inc. (SECZ) — Citigroup downgraded its rating to Neutral from Buy and raised its price target to US$14.00 from US$10.00.
Selective Insurance Group (SIGI) — Oppenheimer reiterated its Outperform rating with a US$115.00 price target.
Semtech (SMTC) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$230.00 from US$155.00.
SentinelOne (S) — Needham & Company LLC maintained its Buy rating and raised its price target to US$31.00 from US$26.00.
ServiceNow (NOW) — Barclays maintained its Overweight rating and raised its price target to US$160.00 from US$134.00.
ServiceNow (NOW) — Evercore reiterated its Outperform rating.
ServiceNow (NOW) — Jefferies reiterated its Buy rating.
ServiceNow (NOW) — Oppenheimer maintained its Outperform rating and raised its price target to US$165.00 from US$140.00.
Sherwin-Williams (SHW) — Barclays initiated coverage with an Equal Weight rating and a US$348.00 price target.
Shift4 Payments (FOUR) — BTIG Research maintained its Buy rating and lowered its price target to US$50.00 from US$60.00.
Shift4 Payments (FOUR) — Raymond James maintained its Outperform rating and lowered its price target to US$50.00 from US$51.00.
Silgan (SLGN) — RBC maintained its Outperform rating and lowered its price target to US$47.00 from US$58.00.
SmartRent (SMRT) — B. Riley initiated coverage with a Buy rating and a US$1.75 price target.
SoFi Technologies (SOFI) — Goldman Sachs set a US$15.00 price target.
Solstice Advance Materials (SOLS) — Barclays initiated coverage with an Overweight rating and a US$73.00 price target.
Southern (SO) — JPMorgan maintained its Neutral rating and lowered its price target to US$94.00 from US$101.00.
Southern (SO) — KeyCorp maintained its Underweight rating and lowered its price target to US$74.00 from US$79.00.
Spire Global (SPIR) — Alliance Global Partners upgraded its rating to Buy from Neutral with a US$15.00 price target.
SPX Technologies (SPXC) — Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$243.00 from US$250.00.
Stellantis (STLA) — Freedom Broker maintained its Buy rating and lowered its price target to US$6.80 from US$7.50.
Sun Communities (SUI) — RBC maintained its Outperform rating and lowered its price target to US$140.00 from US$148.00.
Syndax Pharmaceuticals (SNDX) — HC Wainwright reiterated its Buy rating with a US$38.00 price target.
T. Rowe Price Group (TROW) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$110.00 from US$120.00.
T. Rowe Price Group (TROW) — JPMorgan maintained its Underweight rating and lowered its price target to US$106.00 from US$107.00.
Tandem Diabetes Care (TNDM) — Mizuho set a US$18.00 price target.
Targa Resources (TRGP) — Citigroup maintained its Buy rating and raised its price target to US$325.00 from US$303.00.
Targa Resources (TRGP) — Goldman Sachs reiterated its Buy rating with a US$322.00 price target.
Target (TGT) — Evercore set a US$165.00 price target.
Taylor Devices (TAYD) — Freedom Broker changed its rating to Hold from Buy and lowered its price target to US$65.00 from US$70.00.
TechnipFMC (FTI) — UBS initiated coverage with a Buy rating and a US$89.00 price target.
Telefonica Brasil (VIV) — BofA Securities upgraded its rating to Neutral from Underperform.
TELUS (TU) — Barclays maintained its Equal Weight rating and lowered its price target to US$10.00 from US$11.00.
The Descartes Systems Group (DSGX) — BMO Capital Markets maintained its Market Perform rating and raised its price target to US$90.00 from US$82.00.
The Hanover Insurance Group (THG) — Oppenheimer reiterated its Outperform rating with a US$260.00 price target.
Thermo Fisher Scientific (TMO) — TD Cowen maintained its Buy rating and raised its price target to US$760.00 from US$675.00.
Thomson Reuters (TRI) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$110.00 from US$116.00.
Thor Industries (THO) — Citigroup maintained its Neutral rating and lowered its price target to US$70.00 from US$76.00.
TIM S.A. (TIMB) — BofA Securities upgraded its rating to Neutral from Underperform.
TotalEnergies (TTE) — TD Cowen maintained its Buy rating and lowered its price target to US$105.00 from US$108.00.
Tractor Supply (TSCO) — Citigroup maintained its Buy rating and raised its price target to US$38.00 from US$37.00.
TransMedics Group (TMDX) — Canaccord Genuity maintained its Buy rating and lowered its price target to US$94.00 from US$95.00.
TransUnion (TRU) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$97.00 from US$106.00.
TransUnion (TRU) — Needham & Company LLC maintained its Buy rating and lowered its price target to US$85.00 from US$100.00.
TTM Technologies (TTMI) — Truist maintained its Buy rating and raised its price target to US$231.00 from US$224.00.
Twist Bioscience (TWST) — TD Cowen maintained its Buy rating and raised its price target to US$190.00 from US$115.00.
Unilever (UL) — TD Cowen maintained its Buy rating and lowered its price target to US$74.00 from US$76.00.
United Dominion Realty Trust (UDR) — RBC maintained its Sector Perform rating and lowered its price target to US$37.00 from US$40.00.
UnitedHealth Group (UNH) — UBS reiterated its Outperform rating.
Unity Bancorp (UNTY) — DA Davidson reiterated its Buy rating with a US$68.00 price target.
Unity Software (U) — Morgan Stanley maintained its Overweight rating and raised its price target to US$55.00 from US$50.00.
Upstart (UPST) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$28.00 from US$39.00.
V.F. Corp (VFC) — Piper Sandler upgraded its rating to Overweight from Neutral and raised its price target to US$20.00 from US$16.00.
V.F. Corp (VFC) — Truist upgraded its rating to Buy from Hold and raised its price target to US$20.00 from US$14.00.
Vail Resorts (MTN) — Ladenburg Thalmann initiated coverage with a Buy rating and a US$192.00 price target.
Vale (VALE) — Barclays maintained its Equal Weight rating and lowered its price target to US$15.00 from US$17.00.
Valero Energy (VLO) — Citigroup maintained its Neutral rating and raised its price target to US$485.00 from US$302.00.
Varonis Systems (VRNS) — TD Cowen maintained its Buy rating and raised its price target to US$56.00 from US$53.00.
Ventas (VTR) — Barclays maintained its Equal Weight rating and lowered its price target to US$91.00 from US$102.00.
Verisk Analytics (VRSK) — BMO Capital Markets maintained its Outperform rating and lowered its price target to US$217.00 from US$248.00.
Verisk Analytics (VRSK) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$215.00 from US$235.00.
Verra Mobility (VRRM) — JPMorgan maintained its Neutral rating and lowered its price target to US$5.00 from US$6.00.
Vertex (VERX) — TD Cowen maintained its Buy rating and lowered its price target to US$15.00 from US$16.00.
Viking Holdings Ltd (VIK) — Barclays upgraded its rating to Overweight from Equal Weight with a US$102.00 price target.
Viper Energy (VNOM) — Mizuho set a US$57.00 price target.
Vital Farms (VITL) — TD Cowen maintained its Hold rating and lowered its price target to US$8.00 from US$11.00.
Vivmark Residential Common Shares of Beneficial Interest (VMRK) — RBC maintained its Sector Perform rating and lowered its price target to US$67.00 from US$71.00.
Vulcan Materials (VMC) — JPMorgan maintained its Neutral rating and lowered its price target to US$300.00 from US$320.00.
Waste Connections (WCN) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$195.00 from US$205.00.
Waste Management (WM) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$220.00 from US$230.00.
Waters (WAT) — TD Cowen maintained its Buy rating and raised its price target to US$515.00 from US$475.00.
WEC Energy Group (WEC) — KeyCorp maintained its Overweight rating and lowered its price target to US$111.00 from US$117.00.
Wells Fargo & Company (WFC) — Goldman Sachs set a US$94.00 price target.
Welltower (WELL) — Barclays maintained its Equal Weight rating and lowered its price target to US$246.00 from US$259.00.
West Pharmaceutical Services (WST) — TD Cowen maintained its Buy rating and raised its price target to US$420.00 from US$410.00.
Westlake (WLK) — RBC maintained its Outperform rating and lowered its price target to US$74.00 from US$95.00.
Westlake Corporation (WLK) — Barclays initiated coverage with an Underweight rating and a US$66.00 price target.
Winnebago Industries (WGO) — Citigroup maintained its Neutral rating and lowered its price target to US$24.00 from US$29.00.
Wintrust Fin (WTFC) — Deutsche Bank initiated coverage with a Buy rating and a US$175.00 price target.
Wise Group (WSE) — UBS maintained its Buy rating and raised its price target to US$17.25 from US$16.00.
Wynn Resorts (WYNN) — Goldman Sachs set a US$102.00 price target.
Xcel Energy (XEL) — KeyCorp maintained its Overweight rating and lowered its price target to US$87.00 from US$90.00.
XPLR Infrastructure (XIFR) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$11.00 from US$12.00.
Xylem (XYL) — Barclays maintained its Overweight rating and lowered its price target to US$139.00 from US$159.00.
Yelp (YELP) — Morgan Stanley maintained its Underweight rating and lowered its price target to US$17.00 from US$24.00.
YETI Holdings (YETI) — Ladenburg Thalmann initiated coverage with a Buy rating and a US$52.00 price target.
Zapata Quantum (ZPTA) — Chardan initiated coverage with a Buy rating and a US$1.00 price target.
Zenas BioPharma (ZBIO) — HC Wainwright reiterated its Buy rating with a US$44.00 price target.
Zillow Group (Z) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$35.00 from US$60.00.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.